No significant visual gains seen with PDE6A gene supplementation in early-phase trial
Ophthalmology Times,
A new clinical study1 published in the British Journal of Ophthalmology found that a subretinal gene therapy to treat patients…
A new clinical study1 published in the British Journal of Ophthalmology found that a subretinal gene therapy to treat patients…
Spark Therapeutics Inc (NASDAQ: ONCE), a gene therapy company that treats orphan diseases including a rare retinal disease that…